Elevating fungal care: bridging Brazil’s healthcare practices to global standards

DOI: 10.1128/spectrum.02112-24 Publication Date: 2025-03-10T13:01:51Z
AUTHORS (739)
ABSTRACT
ABSTRACT Brazil faces unique challenges in managing invasive fungal infections (IFIs) due to diverse ecosystems, a rural workforce, and prevalent health conditions. In Europe, IFIs are primarily associated with transplantation, intensive care, chronic diseases. Inspired by initiatives the Caribbean Latin America 2019, efforts map global diagnostic treatment resources expanded Africa, Asia/Pacific. This study conducts comparative analysis, mainly drawing data from investigate IFI epidemiology management. Data were collected through online surveys distributed Brazilian European institutions, collaborations scientific organizations. Surveys covered institutional profiles, diagnoses, accessibility techniques, antifungal drugs. A survey involving 96 388 institutions revealed variations perception practices related pathogens. Differences ranking prevalence observed, along procedures, fluorescence dye usage, culture practices, medication availability, technological approaches. Europe exhibited higher utilization rates for molecular approaches, including PCR tests, therapeutic drug monitoring (TDM) was more widespread compared Brazil, indicating substantial differences understanding infections. Customized management is crucial, considering regional addressing gaps like underutilized PCR. The advocates increased international collaboration, targeted training, enhanced foster unified approach preventing, diagnosing, treating IFI. IMPORTANCE work significant as it highlights its ecosystems public landscape. By comparing Brazil’s situation Europe—where linked transplantation care—this identifies key disparities practices. findings reveal availability use of diagnostics, drugs, monitoring, demonstrating advanced mapping these variations, underscores importance tailored approaches that consider gaps. Ultimately, calls resource allocation improve outcomes globally, particularly regions limited access tools treatments.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (49)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....